54277 studies found for:    Open Studies
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Monocentric Registry to Investigate the Role of Platelet Function, Platelet Pharmacogenomics, Proteomics and Metabonomics in Ischemic and Non-ischemic Heart Disease
Condition: Cardiovascular Disease
Intervention:
2 Recruiting Cortisol and Nutritional Sympathetic Responsiveness
Conditions: Metabolic Syndrome;   Obesity;   Insulin Resistance
Interventions: Drug: metyrapone;   Drug: placebo
3 Recruiting Lenalidomide After Donor Stem Cell Transplant and Bortezomib in Treating Patients With High Risk Multiple Myeloma
Conditions: Refractory Multiple Myeloma;   Stage I Multiple Myeloma;   Stage II Multiple Myeloma;   Stage III Multiple Myeloma
Interventions: Drug: fludarabine phosphate;   Radiation: total-body irradiation;   Procedure: nonmyeloablative allogeneic hematopoietic stem cell transplantation;   Drug: cyclosporine;   Drug: mycophenolate mofetil;   Drug: bortezomib;   Drug: lenalidomide;   Other: laboratory biomarker analysis
4 Recruiting PI3K Inhibitor BKM120 and Cetuximab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Conditions: Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma;   Recurrent Metastatic Squamous Neck Cancer With Occult Primary;   Recurrent Salivary Gland Cancer;   Recurrent Squamous Cell Carcinoma of the Hypopharynx;   Recurrent Squamous Cell Carcinoma of the Larynx;   Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity;   Recurrent Squamous Cell Carcinoma of the Nasopharynx;   Recurrent Squamous Cell Carcinoma of the Oropharynx;   Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity;   Recurrent Verrucous Carcinoma of the Larynx;   Recurrent Verrucous Carcinoma of the Oral Cavity;   Salivary Gland Squamous Cell Carcinoma;   Stage IV Squamous Cell Carcinoma of the Hypopharynx;   Stage IV Squamous Cell Carcinoma of the Nasopharynx;   Stage IVA Salivary Gland Cancer;   Stage IVA Squamous Cell Carcinoma of the Larynx;   Stage IVA Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage IVA Squamous Cell Carcinoma of the Oropharynx;   Stage IVA Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity;   Stage IVA Verrucous Carcinoma of the Larynx;   Stage IVA Verrucous Carcinoma of the Oral Cavity;   Stage IVB Salivary Gland Cancer;   Stage IVB Squamous Cell Carcinoma of the Larynx;   Stage IVB Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage IVB Squamous Cell Carcinoma of the Oropharynx;   Stage IVB Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity;   Stage IVB Verrucous Carcinoma of the Larynx;   Stage IVB Verrucous Carcinoma of the Oral Cavity;   Stage IVC Salivary Gland Cancer;   Stage IVC Squamous Cell Carcinoma of the Larynx;   Stage IVC Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage IVC Squamous Cell Carcinoma of the Oropharynx;   Stage IVC Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity;   Stage IVC Verrucous Carcinoma of the Larynx;   Stage IVC Verrucous Carcinoma of the Oral Cavity;   Tongue Cancer
Interventions: Drug: PI3K inhibitor BKM120;   Biological: cetuximab;   Other: laboratory biomarker analysis;   Other: questionnaire administration
5 Unknown  Adderall XR and Processing Speed in Multiple Sclerosis (MS)
Conditions: Impaired Processing Speed;   Cognitive Impairment;   Multiple Sclerosis
Interventions: Drug: Adderall XR 5mg;   Drug: Adderall XR 10 mg;   Drug: Placebo
6 Not yet recruiting Erlotinib Hydrochloride in Treating Patients With Bladder Cancer Undergoing Surgery
Conditions: Recurrent Bladder Cancer;   Stage I Bladder Cancer;   Stage II Bladder Cancer;   Stage III Bladder Cancer
Interventions: Drug: erlotinib hydrochloride;   Other: placebo;   Procedure: therapeutic conventional surgery;   Other: pharmacological study;   Other: laboratory biomarker analysis
7 Recruiting Role of a Combination of Nutraceuticals (Ritmonutra) on Benign Supraventricular and Ventricular Arrhythmias
Condition: Ventricular and Atrial Extrasytoles
Interventions: Dietary Supplement: Ritmonutra;   Dietary Supplement: placebo
8 Recruiting Comparing Maximal and Half-maximal Suction Pressure Applied During Water Exchange in Colonoscopy
Condition: Minimally Sedated Patient Undergoing Colonoscopy
Interventions: Procedure: half-maximal pressure;   Procedure: maximal pressure;   Device: Suction Unit
9 Recruiting Mechanisms of Pharyngeal Collapse in Sleep Apnea, Study D
Condition: Sleep Apnea
Intervention: Other: Induced central apneas
10 Unknown  Bronchial Inflammation in Patients With Severe Immune Deficiency Under Immunoglobulin Treatment
Condition: Immune Deficiency
Intervention:
11 Unknown  Immune Thrombocytopenia (ITP) Immune-Genetic Assessment
Condition: Thrombocytopenia
Intervention:
12 Recruiting Targeted Ultrasound in Rheumatoid Arthritis
Conditions: Rheumatoid Arthritis;   Targeted Ultrasound
Intervention: Drug: Adalimumab
13 Recruiting Study of Nasal Airflow Pressure Optimization to Resolve Excessive Snoring
Condition: Habitual, Simple Snoring
Intervention: Device: nasal continuous positive airway pressure less than or equal to 6 cm H2O
14 Recruiting Prospective, Non-randomized, Safety and Efficacy Study of a New Occluder Design for Minimally Invasive Closure of the Left Atrial Appendage (LAA) in Patients With Atrial Fibrillation
Condition: Atrial Fibrillation
Intervention: Device: Implantation of LAA closure device
15 Not yet recruiting A Proof of Principle Study of Aminolevulinic Acid (ALA) - Induced Fluorescence Detection in Resectable Non-Small Cell Lung Cancer
Condition: Lung Cancer in Normal and Malignant Tumors
Intervention: Drug: ALA-induced Fluorescence
16 Recruiting Community Intervention to Prevent Nipah Spillover
Condition: Human NiV Infection
Interventions: Behavioral: Ask people not to drink raw sap;   Behavioral: Ask people not to drink sap or drink sap from skirt protected trees;   Other: No Intervention
17 Recruiting Type 1 Diabetes Mellitus Effect on Bone Mineral Density
Conditions: Diabetes Mellitus;   Osteoporosis
Intervention:
18 Recruiting Oocyte Survival After Vitrification in an Open or Closed Device With Closed Storage.
Condition: Survival
Interventions: Device: CBSvit HS device;   Device: Cryotop SC device
19 Unknown  The Safety and Efficacy of Etanercept (Enbrel®) for the Treatment of Discoid Lupus Erythematosus
Condition: Discoid Lupus Erythematosus (DLE)
Intervention: Drug: etanercept(Enbrel®)
20 Unknown  Study of Intravitreal Microplasmin in Relieving Vitreo-Macular Adhesion in Neovascular Age-related Macular Degeneration
Condition: Macular Degeneration
Interventions: Drug: Microplasmin;   Drug: Placebo control

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years